BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Matsumoto H, Tamura S, Kamada Y, Kiso S, Fukushima J, Wada A, Maeda N, Kihara S, Funahashi T, Matsuzawa Y, Shimomura I, Hayashi N. Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice. World J Gastroenterol 2006; 12(21): 3352-3358 [PMID: 16733851 DOI: 10.3748/wjg.v12.i21.3352]
URL: https://www.wjgnet.com/1007-9327/full/v12/i21/3352.htm
(0) (0) (7023) (65)
Number Citing Articles
1
Wen-Ze Xiao, Li Zhang. Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice. Chinese Medical Journal 2019; 132(20) doi: 10.1097/CM9.0000000000000488
2
Yu Wang, Karen S.L. Lam, Aimin Xu. Adiponectin as a therapeutic target for obesity‐related metabolic and cardiovascular disorders. Drug Development Research 2006; 67(8) doi: 10.1002/ddr.20141
3
Amir J. Guri, Josep Bassaganya‐Riera. Systemic Effects of White Adipose Tissue Dysregulation and Obesity‐Related Inflammation. Obesity 2011; 19(4) doi: 10.1038/oby.2010.230
4
Yoshihiro Kamada, Tetsuo Takehara, Norio Hayashi. Adipocytokines and liver disease. Journal of Gastroenterology 2008; 43(11) doi: 10.1007/s00535-008-2213-6
5
Junkwon Cho, Rika Teshigawara, Masahiro Kameda, Shinpei Yamaguchi, Takashi Tada. Nucleus‐localized adiponectin is survival gatekeeper through miR‐214‐mediated AIFM2 regulation. Genes to Cells 2019; 24(2) doi: 10.1111/gtc.12658
6
Mina Hamano, Yoshihiro Kamada, Shinichi Kiso, Kunimaro Furuta, Takashi Kizu, Norihiro Chatani, Mayumi Egawa, Takayo Takemura, Hisao Ezaki, Yuichi Yoshida, Kenji Watabe, Toshimitsu Hamasaki, Miyuki Umeda, Aiko Furubayashi, Kazuo Kinoshita, Osamu Kishida, Takashi Fujimoto, Akira Yamada, Yoshifumi Tsukamoto, Shusaku Tsutsui, Tetsuo Takehara, Norio Hayashi, Yuji Matsuzawa. Adiponectin negatively correlates with alcoholic and non‐alcoholic liver dysfunction: Health check‐up study of Japanese men. Hepatology Research 2013; 43(3) doi: 10.1111/j.1872-034X.2012.01066.x
7
Hirokazu Takahashi, Kazuhiko Kotani, Kenichi Tanaka, Yuichiro Egucih, Keizo Anzai. Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00588
8
Julie Jortay, Maximin Senou, Aurélie Delaigle, Laurence Noel, Tohru Funahashi, Norikazu Maeda, Marie C. Many, Sonia M. Brichard. Local Induction of Adiponectin Reduces Lipopolysaccharide-Triggered Skeletal Muscle Damage. Endocrinology 2010; 151(10) doi: 10.1210/en.2009-1462
9
DONG SHAN YU, FANG MEI AN, BANG DONG GONG, XIAO GANG XIANG, LAN YI LIN, HUI WANG, QING XIE. The regulatory role of microRNA-1187 in TNF-α-mediated hepatocyte apoptosis in acute liver failure. International Journal of Molecular Medicine 2012; 29(4) doi: 10.3892/ijmm.2012.888
10
J. J. O. Turner, M. J. Smolinska, S. M. Sacre, B. M. J. Foxwell. Induction of TLR Tolerance in Human Macrophages by Adiponectin: Does LPS Play a Role?. Scandinavian Journal of Immunology 2009; 69(4) doi: 10.1111/j.1365-3083.2008.02224.x
11
. 2024;  doi: 10.70675/307db8bbz3572z4badz965fz01280273b8c7
12
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
13
Annelise M. Poss, Scott A. Summers. Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00505
14
Makoto Nishida, Tohru Funahashi, Iichiro Shimomura. Pathophysiological significance of adiponectin. Medical Molecular Morphology 2007; 40(2) doi: 10.1007/s00795-007-0366-7
15
Fedor A. Sysonov, Ekaterina A. Gorshkova, Konstantin E. Menshikov, Marina S. Drutskaya, Sergey A. Nedospasov, Ekaterina O. Gubernatorova. Experimental Models of Acute Liver Failure in Mice: From Pathogenesis and Inflammatory Cascades to the Role of Intestine. Biochemistry (Moscow) 2026; 91(8) doi: 10.1134/S000629792660239X
16
Noha F. Hassan, Somaia A. Nada, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Rania M. Abdelsalam. Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis. Inflammation 2019; 42(3) doi: 10.1007/s10753-019-00967-6
17
Juichi Fukushima, Yoshihiro Kamada, Hitoshi Matsumoto, Yuichi Yoshida, Hisao Ezaki, Takayo Takemura, Yukiko Saji, Takumi Igura, Shusaku Tsutsui, Shinji Kihara, Tohru Funahashi, Iichiro Shimomura, Shinji Tamura, Shinichi Kiso, Norio Hayashi. Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization. Hepatology Research 2009; 39(7) doi: 10.1111/j.1872-034X.2009.00509.x
18
T.E. Silva, G. Colombo, L.L. Schiavon. Adiponectin: A multitasking player in the field of liver diseases. Diabetes & Metabolism 2014; 40(2) doi: 10.1016/j.diabet.2013.11.004
19
Yoshitaka Uji, Hiroshi Yamamoto, Kazuhisa Maeda, Hiroshi Tsuchihashi, Hiroya Akabori, Tomoharu Shimizu, Yoshihiro Endo, Iichiro Shimomura, Tohru Tani. Adiponectin Deficiency Promotes the Production of Inflammatory Mediators While Severely Exacerbating Hepatic Injury in Mice with Polymicrobial Sepsis. Journal of Surgical Research 2010; 161(2) doi: 10.1016/j.jss.2008.12.021
20
Katsuhisa Omagari, Chiaki Koba, Asuka Nagata, Linh Chi Thi Ngo, Mayu Yamasaki, Ayumi Fukuda, Masahiro Yuasa, Kazuhito Suruga, Nobutada Inada, Mayuko Ichimura-Shimizu, Koichi Tsuneyama. Olive leaf powder prevents nonalcoholic steatohepatitis in Sprague–Dawley rats fed a high-fat and high-cholesterol diet. Clinical Nutrition Open Science 2021; 37 doi: 10.1016/j.nutos.2021.04.002
21
Carl Weidinger, Britta Siegmund. The Mesentery and Inflammation. Progress in Inflammation Research 2023; 90 doi: 10.1007/978-3-031-17774-3_5
22
George Kolios, Vassilis Valatas, Elias Kouroumalis. Role of Kupffer cells in the pathogenesis of liver disease. World Journal of Gastroenterology 2006; 12(46): 7413-7420 doi: 10.3748/wjg.v12.i46.7413
23
Shinichi Mochizuki, Kazuo Sakurai. Dectin-1 targeting delivery of TNF-α antisense ODNs complexed with β-1,3-glucan protects mice from LPS-induced hepatitis. Journal of Controlled Release 2011; 151(2) doi: 10.1016/j.jconrel.2011.01.026
24
Zhuying Guo, Shiting Wang, Qiang Jiao, Manghua Xu, Zhimei Xu. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats. Biomedicine & Pharmacotherapy 2009; 63(7) doi: 10.1016/j.biopha.2008.08.012
25
Mingyan Zhou, Aimin Xu, Karen S.L. Lam, Paul K.H. Tam, Chi-Ming Che, Lawrence Chan, In-Kyu Lee, Donghai Wu, Yu Wang. Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. Journal of Hepatology 2010; 53(6) doi: 10.1016/j.jhep.2010.05.034
26
Leon An, Xiaodong Wang, Arthur I. Cederbaum. Cytokines in alcoholic liver disease. Archives of Toxicology 2012; 86(9) doi: 10.1007/s00204-012-0814-6
27
Luisa Vonghia, Peter Michielsen, Sven Francque. Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2013; 14(10) doi: 10.3390/ijms141019867
28
Norihiro Chatani, Yoshihiro Kamada, Takashi Kizu, Satoshi Ogura, Kunimaro Furuta, Mayumi Egawa, Mina Hamano, Hisao Ezaki, Shinichi Kiso, Akihiko Shimono, Noriyuki Ouchi, Yuichi Yoshida, Tetsuo Takehara. Secreted frizzled‐related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver International 2015; 35(8) doi: 10.1111/liv.12757
29
Mizuho Hiramatsu-Ito, Rei Shibata, Koji Ohashi, Yusuke Uemura, Noriyoshi Kanemura, Takahiro Kambara, Takashi Enomoto, Daisuke Yuasa, Kazuhiro Matsuo, Masanori Ito, Satoko Hayakawa, Hayato Ogawa, Naoya Otaka, Shinji Kihara, Toyoaki Murohara, Noriyuki Ouchi. Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice. Cardiovascular Research 2016; 110(1) doi: 10.1093/cvr/cvv282
30
Hisao Ezaki, Yuichi Yoshida, Yukiko Saji, Takayo Takemura, Juichi Fukushima, Hitoshi Matsumoto, Yoshihiro Kamada, Akira Wada, Takumi Igura, Shinji Kihara, Tohru Funahashi, Iichiro Shimomura, Shinji Tamura, Shinichi Kiso, Norio Hayashi. Delayed liver regeneration after partial hepatectomy in adiponectin knockout mice. Biochemical and Biophysical Research Communications 2009; 378(1) doi: 10.1016/j.bbrc.2008.10.176
31
Ying Wang, Yumeng Wan, Guihong Ye, Pu Wang, Xiaowen Xue, Guanzhong Wu, Boping Ye. Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice. European Journal of Pharmaceutical Sciences 2016; 93 doi: 10.1016/j.ejps.2016.08.017
32
Andreas Schäffler, Jürgen Schölmerich. The role of adiponectin in inflammatory gastrointestinal diseases. Gut 2009; 58(3) doi: 10.1136/gut.2008.159210
33
Li-Hua Lian, Xuejun Jin, Yan-Ling Wu, Xing Fu Cai, Jung Joon Lee, Ji-Xing Nan. Hepatoprotective Effects of Sedum sarmentosum on D-Galactosamine/Lipopolysaccharide–Induced Murine Fulminant Hepatic Failure. Journal of Pharmacological Sciences 2010; 114(2) doi: 10.1254/jphs.10045FP
34
Mingyan Zhou, Aimin Xu, Paul K. H. Tam, Karen S. L. Lam, Bosheng Huang, Yan Liang, In-Kyu Lee, Donghai Wu, Yu Wang, Sookja Chung. Upregulation of UCP2 by Adiponectin: The Involvement of Mitochondrial Superoxide and hnRNP K. PLoS ONE 2012; 7(2) doi: 10.1371/journal.pone.0032349
35
. 2020;  doi: 10.70675/a3d3dfefzd83dz4502zb987z5b0a8fe8cff5
36
Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Arturo Cesaro, Luca Rinaldi, Teresa Salvatore, Raffaele Marfella, Celestino Sardu, Elisabetta Moscarella, Felice Gragnano, Paolo Calabrò, Ferdinando Carlo Sasso. Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease. Reviews in Cardiovascular Medicine 2021; 22(3) doi: 10.31083/j.rcm2203082
37
Mingyan Zhou, Aimin Xu, Paul K. H. Tam, Karen S. L. Lam, Lawrence Chan, Ruby L. C. Hoo, Jing Liu, Kim H. M. Chow, Yu Wang. Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury†. Hepatology 2008; 48(4) doi: 10.1002/hep.22444
38
Jörn M. Schattenberg, Marcus Schuchmann. Diabetes and apoptosis: liver. Apoptosis 2009; 14(12) doi: 10.1007/s10495-009-0366-2
39
Tohru Funahashi, Yuji Matsuzawa. Adiponectin and the cardiometabolic syndrome: An epidemiological perspective. Best Practice & Research Clinical Endocrinology & Metabolism 2014; 28(1) doi: 10.1016/j.beem.2013.09.002
40
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
41
Muhammad Jahangir Hossen, Md. Abdul Matin, Mahmudul Hasan Sikder, Md. Selim Ahmed, Moizur Rahman. Recent Advancements in Microbial Diversity. 2022;  doi: 10.1016/B978-0-12-822368-0.00016-5
42
Hiroshi Yamamoto, Hajime Nakae, Yoshitaka Uji, Kazuhisa Maeda, Tohru Tani, Yutaka Eguchi. Plasma Adiponectin Levels in Acute Liver Failure Patients Treated with Plasma Filtration with Dialysis and Plasma Exchange. Therapeutic Apheresis and Dialysis 2015; 19(4) doi: 10.1111/1744-9987.12344
43
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1) doi: 10.1210/endrev/bnz009
44
Ling-Ling Jiang, Lin Li, Xiao-Fei Hong, You-Ming Li, Bing-Ling Zhang. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels. European Journal of Gastroenterology & Hepatology 2009; 21(6) doi: 10.1097/MEG.0b013e328317f4b5
45
Noha F. Hassan, Azza H. Hassan, Mona R. El-Ansary. Cytokine modulation by etanercept ameliorates metabolic syndrome and its related complications induced in rats administered a high-fat high-fructose diet. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24593-9
46
Maria Pini, Joseph A. Sennello, Lawrence Chan, Giamila Fantuzzi. Adiponectin Deficiency Does Not Affect the Inflammatory Response to Endotoxin or Concanavalin A in Mice. Endocrinology 2006; 147(11) doi: 10.1210/en.2006-0855
47
Jason M Konter, Jennifer L Parker, Elizabeth Baez, Stephanie Z Li, Barbara Ranscht, Martin Denzel, Frederic F Little, Kazuto Nakamura, Noriyuki Ouchi, Alan Fine, Kenneth Walsh, Ross S Summer. Adiponectin Attenuates Lipopolysaccharide-Induced Acute Lung Injury through Suppression of Endothelial Cell Activation. The Journal of Immunology 2012; 188(2) doi: 10.4049/jimmunol.1100426
48
Tomonori Aoyama, Kenichi Ikejima, Kazuyoshi Kon, Kyoko Okumura, Kumiko Arai, Sumio Watanabe. Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-Ay mice #. Hepatology 2009; 49(5) doi: 10.1002/hep.22828
49
Raja Fayad, Maria Pini, Joseph A. Sennello, Robert J. Cabay, Lawrence Chan, Aimin Xu, Giamila Fantuzzi. Adiponectin Deficiency Protects Mice From Chemically Induced Colonic Inflammation. Gastroenterology 2007; 132(2) doi: 10.1053/j.gastro.2006.11.026
50
Fabio Salvatore Macaluso, Marcello Maida, Salvatore Petta. Genetic background in nonalcoholic fatty liver disease: A comprehensive review. World Journal of Gastroenterology 2015; 21(39): 11088-11111 doi: 10.3748/wjg.v21.i39.11088
51
Anel Hernández-Garces, José Agustín García Reynoso, Yasser Morera‐Gómez. Impact of radioactive emissions from the Laguna Verde nuclear power plant using CALPUFF. Annals of Nuclear Energy 2024; 205 doi: 10.1016/j.anucene.2024.110603
52
Shuji Terai, Toshihiko Matsumoto, Isao Sakaida. . Folia Pharmacologica Japonica 2007; 129(4) doi: 10.1254/fpj.129.271
53
Pil-hoon Park, Megan R. McMullen, Honglian Huang, Varsha Thakur, Laura E. Nagy. Short-term Treatment of RAW264.7 Macrophages with Adiponectin Increases Tumor Necrosis Factor-α (TNF-α) Expression via ERK1/2 Activation and Egr-1 Expression. Journal of Biological Chemistry 2007; 282(30) doi: 10.1074/jbc.M701419200
54
Yu Wang, Mingyan Zhou, Karen S. L. Lam, Aimin Xu. Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. Arquivos Brasileiros de Endocrinologia & Metabologia 2009; 53(2) doi: 10.1590/S0004-27302009000200012
55
S. Esmaili, M. Hemmati, M. Karamian. Physiological role of adiponectin in different tissues: a review. Archives of Physiology and Biochemistry 2020; 126(1) doi: 10.1080/13813455.2018.1493606
56
Mariana Mendes-Braz, Joilson O. Martins. Diabetes Mellitus and Liver Surgery: The Effect of Diabetes on Oxidative Stress and Inflammation. Mediators of Inflammation 2018; 2018 doi: 10.1155/2018/2456579
57
Hideharu Ogiyama, Yoshihiro Kamada, Shinichi Kiso, Hiroshi Araki, Takuya Yamada, Tamao Nishihara, Kenji Watabe, Yoshihiro Tochino, Shinji Kihara, Tohru Funahashi, Keishi Kanno, Iichiro Shimomura, Shusaku Tsutsui, Susumu Tazuma, Norio Hayashi. Lack of adiponectin promotes formation of cholesterol gallstones in mice. Biochemical and Biophysical Research Communications 2010; 399(3) doi: 10.1016/j.bbrc.2010.07.075
58
Katsutoshi Tokushige, Etsuko Hashimoto, Haruka Noto, Satoru Yatsuji, Makiko Taniai, Nobuyuki Torii, Keiko Shiratori. Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. Journal of Gastroenterology 2009; 44(9) doi: 10.1007/s00535-009-0085-z
59
Luisa Vonghia, Sven Francque. Cross talk of the immune system in the adipose tissue and the liver in non-alcoholic steatohepatitis: Pathology and beyond. World Journal of Hepatology 2015; 7(15): 1905-1912 doi: 10.4254/wjh.v7.i15.1905
60
Yoshihiro Kamada, Tadashi Nakamura, Tohru Funahashi, Miwa Ryo, Hitoshi Nishizawa, Yukiyoshi Okauchi, Juichi Fukushima, Yuichi Yoshida, Shinichi Kiso, Iichiro Shimomura, Norio Hayashi. Visceral Obesity and Hypoadiponectinemia are Significant Determinants of Hepatic Dysfunction. Journal of Clinical Gastroenterology 2009; 43(10) doi: 10.1097/MCG.0b013e3181962de8
61
Motohiko Kato, Kenji Watabe, Toshimitsu Hamasaki, Miyuki Umeda, Aiko Furubayashi, Kazuo Kinoshita, Osamu Kishida, Takashi Fujimoto, Akira Yamada, Yoshifumi Tsukamoto, Shunsuke Yamamoto, Yoshihiro Kamada, Yuichi Yoshida, Shinichi Kiso, Shusaku Tsutsui, Shinji Kihara, Norio Hayashi, Yuji Matsuzawa. Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups. Journal of Gastroenterology 2011; 46(12) doi: 10.1007/s00535-011-0453-3
62
Jun Ren, Xihui Xu, Qiurong Wang, Sidney Y. Ren, Maolong Dong, Yingmei Zhang. Permissive role of AMPK and autophagy in adiponectin deficiency-accentuated myocardial injury and inflammation in endotoxemia. Journal of Molecular and Cellular Cardiology 2016; 93 doi: 10.1016/j.yjmcc.2016.02.002
63
Takeshi Hijikawa, Masaki Kaibori, Yoichiro Uchida, Masanori Yamada, Kosuke Matsui, Takashi Ozaki, Yasuo Kamiyama, Mikio Nishizawa, Tadayoshi Okumura. INSULIN-LIKE GROWTH FACTOR 1 PREVENTS LIVER INJURY THROUGH THE INHIBITION OF TNF-α AND INOS INDUCTION IN D-GALACTOSAMINE AND LPS-TREATED RATS. Shock 2008; 29(6) doi: 10.1097/SHK.0b013e31815d0780
64
Ding Liu, Shengyu Li, Zhihong Li. Adiponectin: A biomarker for chronic hepatitis C?. Cytokine 2017; 89 doi: 10.1016/j.cyto.2015.10.016
65
Giamila Fantuzzi. Adiponectin in inflammatory and immune-mediated diseases. Cytokine 2013; 64(1) doi: 10.1016/j.cyto.2013.06.317
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.